| __timestamp | Halozyme Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 519428000 |
| Thursday, January 1, 2015 | 105812000 | 906794000 |
| Friday, January 1, 2016 | 113485000 | 1491717000 |
| Sunday, January 1, 2017 | 285461000 | 2213533000 |
| Monday, January 1, 2018 | 141726000 | 2638058000 |
| Tuesday, January 1, 2019 | 150446000 | 3615063000 |
| Wednesday, January 1, 2020 | 224227000 | 5469383000 |
| Friday, January 1, 2021 | 361897000 | 6670200000 |
| Saturday, January 1, 2022 | 520812000 | 7850400000 |
| Sunday, January 1, 2023 | 636892000 | 8607000000 |
| Monday, January 1, 2024 | 855907000 | 9489600000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, understanding financial performance is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated has consistently outperformed Halozyme Therapeutics, Inc. in terms of gross profit. From 2014 to 2023, Vertex's gross profit surged by over 1,500%, reaching approximately $8.6 billion in 2023. In contrast, Halozyme's growth, while impressive, was more modest, with a 1,100% increase, culminating in a gross profit of around $637 million in the same year.
This stark difference highlights Vertex's dominant position in the market, driven by its innovative treatments and strategic investments. Meanwhile, Halozyme's steady growth reflects its niche focus and potential for future expansion. As the biotech industry continues to evolve, these trends offer valuable insights into the financial health and strategic direction of these two key players.
Gross Profit Trends Compared: Johnson & Johnson vs Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: Novartis AG vs Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated vs Teva Pharmaceutical Industries Limited: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Grifols, S.A.
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs HUTCHMED (China) Limited
Gross Profit Trends Compared: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Exelixis, Inc. and Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Halozyme Therapeutics, Inc. and Grifols, S.A.
Halozyme Therapeutics, Inc. vs Vericel Corporation: A Gross Profit Performance Breakdown